Diabetes is a long term condition that affects the body’s ability to process glucose. People with diabetes have an increased risk of developing a number of serious health problems. Consistently high blood glucose levels can lead to serious diseases affecting the heart and blood vessels, eyes, kidneys, nerves and teeth. In addition, people with diabetes also have a higher risk of developing infections. In almost all high-income countries, diabetes is a leading cause of cardiovascular disease, blindness, kidney failure, and lower limb amputation. Maintaining blood glucose levels close to normal can help delay or prevent diabetes complications. Therefore people with diabetes need to perform regular blood glucose monitoring to allow them to keep their glucose levels controlled and to inform their treatment changes.
The International Diabetes Federation (IDF) and International Study for Paediatric and Adolescent Diabetes (IPSAD) 2011 Guideline for Diabetes in Childhood and Adolescence recommend self-monitoring of blood glucose as an essential tool for the management of diabetes in these groups. They recognise that without regular monitoring the risks of acute diabetes crises and long term complications are increased. Any strategy therefore that would encourage more frequent blood glucose testing and lead to improved glucose control in young people with diabetes would be welcome.
Initially in collaboration with NHS Greater Glasgow and Clyde, we have developed a real-time monitoring platform for diabetes and other long-term conditions that allows clinicians to monitor their patients in real-time. The platform collects data from patients, such as their blood glucose level, urine ketone level or blood ketone level, blood pressure, temperature and pulse. This data is sent to a server for analysis using National Institute for Health Care Excellence (NICE) guidelines and alerts raised if any readings are outside normal limits (the clinician can customise these limits for each of their patients). A real-time dashboard is provided to let a clinician see the health of their patients at any time. The platform also provides private text messaging and video conferencing between clinician and patient.
This platform is now available under license. For any enquiries, please email: Professor Thomas M Connolly (firstname.lastname@example.org).